NMR ‐identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc‐associated factor X
Protein Science · 2024
DOI: 10.1002/pro.4849 ↗At a glance
Journal article in Protein Science, 2024. Written by Ludovica Martina Epasto and 7 co-authors. Institution: Faculty of Chemistry, Institute for Biological Chemistry, University of Vienna, Vienna, Austria. Major MEDLINE topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, BRCA1 Protein. Cited 2 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme, French National Research Agency, Agence Nationale de la Recherche.
Abstract (original language)
The breast cancer susceptibility 1 (BRCA1) protein plays a pivotal role in modulating the transcriptional activity of the vital intrinsically disordered transcription factor MYC. In this regard, mutations of BRCA1 and interruption of its regulatory activity are related to hereditary breast and ovarian cancer (HBOC). Interestingly, so far, MYC's main dimerization partner MAX (MYC‐associated factor X) has not been found to bind BRCA1 despite a high sequence similarity between both oncoproteins. Herein, we show that a potential reason for this discrepancy is the heterogeneous conformational space of MAX, which encloses a well‐documented folded coiled‐coil homodimer as well as a less common intrinsically disordered monomer state—contrary to MYC, which exists mostly as intrinsically disordered protein in the absence of any binding partner. We show that when the intrinsically disordered state of MAX is artificially overpopulated, the binding of MAX to BRCA1 can readily be observed. We characterize this interaction by nuclear magnetic resonance (NMR) spectroscopy chemical shift and relaxation measurements, complemented with ITC and SAXS data. Our results suggest that BRCA1 directly binds the MAX monomer to form a disordered complex. Though probed herein under biomimetic in‐vitro conditions, this finding can potentially stimulate new perspectives on the regulatory network around BRCA1 and its involvement in MYC:MAX regulation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Chemistry, Institute for Biological Chemistry, University of Vienna, Vienna, Austria.
- Vienna Doctoral School in Chemistry (DoSChem), University of Vienna, Vienna, Austria.
- Faculty of Physics, University of Vienna, Vienna, Austria.
- CNRS UMR 8516, LASIRE, University of Lille, Villeneuve d'Ascq Cedex, France.
- Universite Grenoble Alpes, Grenoble, France.
ORCID profiles: Dennis Kurzbach
Funding
- European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme
- French National Research Agency
- Agence Nationale de la Recherche
Cite
APA
Epasto, L. M., Pötzl, C., Peterlik, H., Khalil, M., Saint-Pierre, C., Gasparutto, D., Sicoli, G., & Kurzbach, D. (2024). NMR ‐identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc‐associated factor X. Protein Science. https://doi.org/10.1002/pro.4849
Vancouver
Epasto LM, Pötzl C, Peterlik H, Khalil M, Saint-Pierre C, Gasparutto D, et al. NMR ‐identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc‐associated factor X. Protein Science. 2024. doi:10.1002/pro.4849
BibTeX
@article{Epasto2024,
author = {Epasto, Ludovica Martina and Pötzl, Christopher and Peterlik, Herwig and Khalil, Mahdi and Saint-Pierre, Christine and Gasparutto, Didier and Sicoli, Giuseppe and Kurzbach, Dennis},
title = {NMR ‐identification of the interaction between BRCA1 and the intrinsically disordered monomer of the Myc‐associated factor X},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.4849}
}
EUVIMED